Search

Your search keyword '"Tsubosa Y"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Tsubosa Y" Remove constraint Author: "Tsubosa Y"
160 results on '"Tsubosa Y"'

Search Results

1. The influence of anastomotic techniques on postoperative anastomotic complications: Results of the Oesophago-Gastric Anastomosis Audit

2. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA)

3. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA)

4. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

5. Postoperative outcomes in oesophagectomy with trainee involvement

6. Textbook outcome following oesophagectomy for cancer: international cohort study

7. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma

8. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

9. Postoperative outcomes in oesophagectomy with trainee involvement

10. Postoperative outcomes in oesophagectomy with trainee involvement

15. 61. Evaluation of the regional lymph node for cervical esophageal squamous cell carcinoma: Proposed selection for improved survival stratification

18. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma

21. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.

26. A multicenter randomized phase II (rPII)/III study comparing concurrent chemoradiotherapy (CRT) with low-dose cisplatin plus continuous infusion of 5-fluorouracil (LDPF) and standard-dose PF (SDPF) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus (JCOG0303).

34. Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: Experience from a single institution

35. A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy.

36. Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.

37. Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial.

38. Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109.

39. Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report.

40. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.

42. Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.

43. Genetic and Immunological Characterization of Brain Metastases from Solid Cancers.

44. Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer.

45. Clinical Significance of Albumin-Bilirubin Grade in Thoracic Esophageal Squamous Cell Carcinoma.

46. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).

47. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.

48. Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.

49. Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma.

50. Ramelteon and suvorexant for postoperative delirium in elderly patients with esophageal cancer.

Catalog

Books, media, physical & digital resources